Protonix and Camptosar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Protonix (pantoprazole sodium) and Camptosar (irinotecan hydrochloride). Common drug interactions include fatigue among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Protonix and Camptosar. It is created by eHealthMe based on reports of 53 people who take the same drugs from the FDA, and is updated regularly.

What is Protonix?

Protonix has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 132,658 Protonix users. Check the latest studies of Protonix.

What is Camptosar?

Camptosar has active ingredients of irinotecan hydrochloride. eHealthMe is studying from 7,145 Camptosar users. Check the latest studies of Camptosar.

On Jul, 13, 2026

53 people who take Protonix and Camptosar together, and have interactions are studied.

Protonix and Camptosar drug interactions.

What are the common drug interactions of Protonix and Camptosar, by gender? *:

female:

Fatigue (feeling of tiredness)
Haemoglobin decreased
Hypotension (abnormally low blood pressure)
Anaemia (lack of blood)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Back pain
Blood glucose increased
Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
Diarrhoea
Hypocalcaemia (levels of calcium in blood serum are abnormally low)

male:

Death
Nausea (feeling of having an urge to vomit)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Neutropenia (an abnormally low number of neutrophils)
Pyrexia (fever)
Abdominal hernia
Abscess oral (abscess in the mouth)
Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
Arteriosclerosis (thickening and hardening of arteries)
Atelectasis (partial or complete collapse of the lung)

What are the common drug interactions of Protonix and Camptosar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Death
Vomiting
Alopecia (absence of hair from areas of the body)
Asthenia (weakness)
Bone marrow failure
Confusional state
Decreased appetite
Dehydration (dryness resulting from the removal of water)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Diarrhoea

30-39:

n/a

40-49:

Abdominal pain
Anaemia (lack of blood)
Pancreatic carcinoma (pancreatic cancer)
Disease progression
Malignant neoplasm progression (cancer tumour came back)

50-59:

Back pain
Blood glucose increased
Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
Haemoglobin decreased
Peripheral motor neuropathy (muscles in the body become progressively weaker over months to years)
Sensation of heaviness
Syncope (loss of consciousness with an inability to maintain postural tone)
Urinary incontinence (inability to control the flow of urine and involuntary urination)
Cardiac arrest
Central nervous system lesion (an abnormality in tissue of brain or spinal cord)

60+:

Dyspnoea (difficult or laboured respiration)
Pulmonary embolism (blockage of the main artery of the lung)
Arteriosclerosis (thickening and hardening of arteries)
Atelectasis (partial or complete collapse of the lung)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Back pain
Bone disorder
Bone neoplasm malignant (cancer of bone)
Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
Cardiomegaly (increased size of heart than normal)

What are the existing conditions these people have? *

Colon Cancer: 11 people, 20.75%
Multiple Myeloma (cancer of the plasma cells): 9 people, 16.98%
Brain Neoplasm Malignant (brain cancer tumour): 7 people, 13.21%
Pancreatic Carcinoma (pancreatic cancer): 4 people, 7.55%
Colon Cancer Metastatic (cancer of colon spreads to other part of body): 4 people, 7.55%
Pain: 3 people, 5.66%
Oesophageal Carcinoma (cancer tumour of oesophagus): 3 people, 5.66%
Nausea (feeling of having an urge to vomit): 3 people, 5.66%

* Approximation only. Some reports may have incomplete information.

Do you take Protonix and Camptosar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously